title: Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
authors.affiliation: Department of Nuclear Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands.
authors.forename: Adrienne
authors.initials: A
authors.lastname: Brouwers
authors.forename: Peter
authors.initials: P
authors.lastname: Mulders
authors.forename: Egbert
authors.initials: E
authors.lastname: Oosterwijk
authors.forename: Wilhelmina
authors.initials: W
authors.lastname: Buijs
authors.forename: Frans
authors.initials: F
authors.lastname: Corstens
authors.forename: Otto
authors.initials: O
authors.lastname: Boerman
authors.forename: Wim
authors.initials: W
authors.lastname: Oyen
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics; D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging*; D006801:Humans; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D007457:Iodine Radioisotopes; D007553:Isotope Labeling; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008875:Middle Aged; D010865:Pilot Projects; D011786:Quality Control; D016719:Radioimmunodetection
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D007457:Iodine Radioisotopes